Ladder Therapeutics

Ladder Bio

This biotechnology company develops ladder-shaped therapeutic molecules to provide pharmaceutical partners with oral medicines for targets that are currently difficult to drug.

Cime Therapeutics

The company develops an automated drug discovery platform using synthetic chemistry and artificial intelligence to create therapeutic molecules for pharmaceutical organisations.

TwoStep Therapeutics

The company develops peptide-drug conjugates and targeted therapies for patients with solid tumours.

Araris Biotech

This company develops antibody-drug conjugate linker technology and targeted cancer therapies for pharmaceutical partners and patients.

Alpha-9 Theranostics

This clinical-stage biotechnology company develops targeted radiopharmaceuticals to treat cancer patients by delivering radiation directly to tumours while sparing healthy tissue.

Synthetic biology-powered mRNA therapeutics

The company develops programmable mRNA therapies using synthetic biology genetic circuits to deliver precise treatments for patients with cancer and other complex diseases.

Ambagon Therapeutics

The company develops small-molecule stabilisers to modulate protein interactions for the treatment of cancer and other serious diseases.

ProteoValent Therapeutics

This company develops targeted protein degrader therapies for cancer and haematology patients.